HomeShopTesamorelin 20 mg
Tesamorelin 20 mg 20 mg - Research Peptide | Pepcore

Tesamorelin 20 mg

129.00
In Stock
Size
Optional Lab Accessories
Bacteriostatic Water
Insulin Needles
Alcohol Swabs
1

For laboratory research use only. Not for human or veterinary use.

1–2 day delivery
1–2 day delivery
EU-wide tracked shipping
≥99% HPLC Purity
≥99% HPLC Purity
Third-party batch verified
COA Included
Lab report with every order
Discreet shipping
Secure & private packaging
Secure Payments
PayPalSEPABitcoin
Order before 12:00 for same-day shipping
Order now, ships next business day
OrderedToday
Shipped13 Apr
Delivered14 Apr16 Apr
Product Specifications
Format
Lyophilized powder
Strength
20 mg
Purity
99%
Testing
Third-party HPLC/MS
CAS
218949-48-5
Intended use
Research only

Description

Tesamorelin 20mg peptide is a synthetic analogue of growth hormone–releasing hormone (GHRH) studied for its ability to stimulate endogenous pulsatile growth hormone secretion through physiological GHRH receptor signaling pathways. In laboratory settings, tesamorelin is used to investigate pituitary-mediated growth hormone release, downstream insulin-like growth factor-1 (IGF-1) responses, and the relationship between GHRH receptor activation and broader metabolic regulation.

Research interest in Tesamorelin 20mg peptide centers on its effects on visceral adiposity, growth hormone pulsatility, and endocrine-metabolic signaling. Published studies have shown that tesamorelin increases endogenous GH pulsatility and raises IGF-1 in controlled research settings, supporting its use as a mechanistic tool for examining how GHRH analogue signaling influences body-composition and metabolic endpoints (Stanley et al., 2011 — Journal of Clinical Endocrinology & Metabolism). Additional clinical and translational work has associated tesamorelin with reductions in visceral adipose tissue and related metabolic changes in research populations, making it a relevant compound for studies of adipose biology, lipid metabolism, and hormone-regulated energy balance (Makimura et al., 2012 — Journal of Clinical Endocrinology & Metabolism).

Current research applications for Tesamorelin 20mg peptide include growth hormone axis studies, visceral adiposity models, endocrine signaling research, and liver-focused metabolic investigations. More recent work has also examined tesamorelin in HIV-associated NAFLD research, where investigators reported reductions in liver fat and prevention of fibrosis progression over one year, while transcriptomic analyses suggested effects on pathways related to oxidative metabolism, inflammation, and tissue repair (Stanley et al., 2019 — Lancet HIV; Fourman et al., 2020 — JCI Insight). Because the strongest public evidence is mechanistic and clinical-research oriented, conservative research-focused language is the most credible way to position tesamorelin on this page.

The peptide is supplied as a lyophilized powder to ensure optimal stability during storage and handling. COA included with every order. See also: Tirzepatide, AOD-9604, HCG 1000 IU

Related products

129.00